MedPath

Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)

Conditions
Chronic Kidney Disease
Registration Number
NCT03246204
Lead Sponsor
Chinese PLA General Hospital
Brief Summary

The study is an observational, multicenter, prospective cohort study aimed at evaluating a 5-year screening programme for chronic kidney disease(CKD) in a population of elderly patients, aged 65 years or more, in China.To analyze the etiology and composition spectrum, the incidence of complications and co-morbidities.To assess the correlation between daily living ability, mental and physical function, quality of life, nutritional status and prognosis.To develop biomarkers of renal aging.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • age≥65 years
  • clinical diagnosis of CKD
  • signed informed consent
Exclusion Criteria
  • subjects who have a poor compliance and cannot be scheduled for follow-up
  • subjects participating in other interventional clinical trials
  • ESRD or dialysis
  • Acute kidney injury(AKI)
  • history of solid organ or bone marrow transplantation
  • active malignancy within 24 months prior to screening or metastatic cancer
  • life expectancy less than 6 months;
  • severe cognitive impairment(NYHA III or IV)
  • HIV infection or AIDS
  • subjects cannot be able to complete the assessment including dementia or other mental disorders, limited physical activity, severe visual impairment
  • simple hematuria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eGFR decline≥40%5 year
Death5 year
Incidence of End Stage Renal Disease (ESRD)5 year

ESRD will be defined as estimated glomerular filtration rate(eGFR)\<15 mL/min/1.73 m2 or dialysis

Secondary Outcome Measures
NameTimeMethod
Heart failure5 year
Acute coronary syndrome5 year
Peripheral arterial disease5 year
Cerebral stroke5 year
© Copyright 2025. All Rights Reserved by MedPath